Sunday, December 1, 2019

Biocon Biologics to reduce the cost of human insulin and cancer drugs

The Biocon subsidiary will chart a path that ensures high volumes and lowcosts, unlike competitors, Christiane Hamacher, chief executive of Biocon Biologics told ET. https://ift.tt/2RcdZVI https://ift.tt/eA8V8J
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

A profile of Netflix co-CEO Greg Peters, who led the company's successful crackdown on password sharing and is now pushing a focus on live programming (Lucas Shaw/Bloomberg)

Lucas Shaw / Bloomberg : A profile of Netflix co-CEO Greg Peters, who led the company's successful crackdown on password sharing and ...